Skip Main Navigation
Page Content
This event has ended

Save This Event

Event Saved

CLSA California Life Sciences Association

Choose your Exit: How to Benefit from IPO Preparation

California Life Sciences Association

Thursday, October 20, 2016 from 11:00 AM to 1:00 PM (PDT)

Who's Going

Loading your connections...

Event Details

Time/Agenda

11:00am | Registration
11:30am – 12:30pm | Program
12:30 – 1:00pm | Networking

 

Now that you have made your idea into a company and are moving forward with product development, what’s your plan? Do you know how to get your product through clinical trials and to the market? What finance strategies are you considering: M&A, IPO, partnering, or all of the above? There are many questions to answer when building your strategy. 

Join us for a lunch to discuss the questions on how to prepare your company for IPO as well as the key differences between M&A and IPO exits.

 

Discussion areas will include:
• Key decisions to make and when to make them
• The right time to develop your exit strategy
• Differences between M&A and IPO exits
• Job Act requirements
• SEC requirements for IPO and post-IPO
• Key stakeholders to manage throughout the process
• Pre- and post-IPO internal processes

Deloitte professionals will share their experiences working with start-up life sciences companies through the IPO process and beyond. The skills learned during this program may be valuable to young companies whether or not they eventually go through an IPO.

Speakers:
Angela Rusakova

Lead Client Service and Audit Partner
Deloitte & Touche LLP

Relevant Experience
Angela has over 20 years of experience serving both public and private companies with a focus on the life sciences industry. She works with companies in all stages of growth, from start-ups to SEC registrants. Her technical background includes complex accounting issues such as revenue recognition, equity, derivatives, stock-based compensation, and acquisitions. Angela has been involved in financing and M&A transactions, including initial public offerings, offerings in leveraged buyouts, and several secondary shares offerings. She has extensive international experience and is a certified public accountant in the United States and the United Kingdom. Angela also served as a CFO before returning to public accounting in 2003.

Selected Clients Served:
Adverum Biotechnologies, Atara Biotherapeutics, Thoratec Corporation, 3V Biotechnologies, Rennovia, Procept Biorobotics, CardioKenetix, CRC Health, Dionex, FireEye, Impac Medical – Elekta, Natus Medical, Pivot Medical, Prenumbra, Spiracur, SquareOne, Vioptix

 

About Deloitte:
At Deloitte, we focus on helping life sciences clients transform their strategic vision into innovative, practical solutions that support their business goals, today and tomorrow. Deloitte’s Life Sciences & Health Care practice is among the largest in the world, leveraging the extensive knowledge, skills and experience of over 9,000 professionals in 99 countries around the world and over 5,000 professionals in the United States. Our practice offers a distinctive menu of professional services delivered in an integrated approach that address all segments of the health plan, health provider and life sciences industries.


Have questions about Choose your Exit: How to Benefit from IPO Preparation? Contact California Life Sciences Association

When & Where


CLSA Event Center
250 E. Grand Ave. Suite 26
South San Francisco, CA 94080

Thursday, October 20, 2016 from 11:00 AM to 1:00 PM (PDT)


  Add to my calendar

Organizer

California Life Sciences Association

California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

  Contact the Organizer
Choose your Exit: How to Benefit from IPO Preparation
Things to do in South San Francisco, CA Conference Science & Tech

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.